Company Profile

Frugi Biotechnology Inc
Profile last edited on: 4/14/22      CAGE: 8RKF8      UEI: KCQAV3ZMDAM9

Business Identifier: Synthetic biology company: modular, paper-based, secure diagnostics for viral outbreak management
Year Founded
First Award
Latest Award
Program Status
Active (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2501 North Loop Drive Suite 1000
Ames, IA 50010
   (603) 812-3212
Location: Single
Congr. District: 04
County: Story

Public Profile

​As of March 2022, Frugi Biotechnology was acquired by and now functions as a wholly-owned subsidiary of BigHat Biosciences - a CA firm having a protein therapeutics company that has developed an antibody design platform guided by artificial intelligence. Frugi Biotechology Inc is described as synthetic biology company structured around creating modular, paper-based, secure diagnostics for viral outbreak management. From the premise that Cell free expression (CFE) has the potential to unlock advanced diagnostic and drug discovery platforms, Frugi Biotechnology management indicate the firm's focus is that of making the most cost-effective and reliable expression system available for these applications. initial focus on frugal cell free extract was founded in development of a paper-based, mail-safe platform which was supported by a RAPID NSF PFI project conducted at Iowa State University. The underlying cell free components are the current research and product Frugi's focus.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $256,000
Project Title: Modular, Paper-based, Secured Diagnostics for Managing Viral Outbreaks (COVID-19)

Key People / Management

  Adam Carr

  Jared Dopp -- Co-Founder and Vice President of Technology

Company News

There are no news available.